These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 7617976)
21. Increased endothelin-1 levels of BAL fluid in patients with pulmonary sarcoidosis. Terashita K; Kato S; Sata M; Inoue S; Nakamura H; Tomoike H Respirology; 2006 Mar; 11(2):145-51. PubMed ID: 16548898 [TBL] [Abstract][Full Text] [Related]
22. Pneumocystis carinii alters surfactant protein A concentrations in bronchoalveolar lavage fluid. Sternberg RI; Whitsett JA; Hull WM; Baughman RP J Lab Clin Med; 1995 Apr; 125(4):462-9. PubMed ID: 7706901 [TBL] [Abstract][Full Text] [Related]
23. Elevated levels of interferon gamma-inducible protein-10 and epithelial neutrophil-activating peptide-78 in patients with pulmonary sarcoidosis. Sugiyama K; Mukae H; Ishii H; Kakugawa T; Ishimoto H; Nakayama S; Shirai R; Fujii T; Mizuta Y; Kohno S Respirology; 2006 Nov; 11(6):708-14. PubMed ID: 17052298 [TBL] [Abstract][Full Text] [Related]
24. Spontaneous hydrogen peroxide release from alveolar macrophages of patients with active sarcoidosis: comparison with cigarette smokers. Baughman RP; Lower EE; Pierson G; Strohofer S J Lab Clin Med; 1988 Apr; 111(4):399-404. PubMed ID: 3127508 [TBL] [Abstract][Full Text] [Related]
25. [Phospholipids and fatty acids in pulmonary surfactant of patients with lung cancer]. Jabłonka S; Ledwozyw A; Kadziołka W; Modrzewski Z Pneumonol Pol; 1989 May; 57(5):270-6. PubMed ID: 2633144 [TBL] [Abstract][Full Text] [Related]
26. Adenosine deaminase activity and fibronectin levels in bronchoalveolar lavage fluid in sarcoidosis and tuberculosis. Albera C; Mabritto I; Ghio P; Solidoro P; Marchetti L; Pozzi E Sarcoidosis; 1993 Mar; 10(1):18-25. PubMed ID: 7907809 [TBL] [Abstract][Full Text] [Related]
29. Integrity of the alveolar-capillary barrier and alveolar surfactant system in smokers. Schmekel B; Bos JA; Khan AR; Wohlfart B; Lachmann B; Wollmer P Thorax; 1992 Aug; 47(8):603-8. PubMed ID: 1412116 [TBL] [Abstract][Full Text] [Related]
30. Pulmonary surfactant in patients with Pneumocystis pneumonia and acquired immunodeficiency syndrome. Schmidt R; Markart P; Ruppert C; Temmesfeld B; Nass R; Lohmeyer J; Seeger W; Günther A Crit Care Med; 2006 Sep; 34(9):2370-6. PubMed ID: 16849999 [TBL] [Abstract][Full Text] [Related]
31. [Effects of age and smoking on the disaturated phosphatidylcholine content of broncho-alveolar lavage fluid]. Yasuoka S; Kawano T; Nakanishi Y; Tani K; Noda Y; Fijisawa K; Ozaki T; Ogura T Nihon Kyobu Shikkan Gakkai Zasshi; 1987 Jul; 25(7):731-7. PubMed ID: 3694953 [No Abstract] [Full Text] [Related]
32. Early effects of short-time cigarette smoking on the human lung: a study of bronchoalveolar lavage fluids. Mancini NM; Béné MC; Gérard H; Chabot F; Faure G; Polu JM; Lesur O Lung; 1993; 171(5):277-91. PubMed ID: 8412308 [TBL] [Abstract][Full Text] [Related]
33. Recoveries of phosphatidylcholine and alveolar macrophages in lung lavage from healthy light smokers. Schmekel B; Khan AR; Linden M; Wollmer P Clin Physiol; 1991 Sep; 11(5):431-8. PubMed ID: 1934939 [TBL] [Abstract][Full Text] [Related]
34. Decreased surfactant lipids correlate with lung function in chronic obstructive pulmonary disease (COPD). Agudelo CW; Kumley BK; Area-Gomez E; Xu Y; Dabo AJ; Geraghty P; Campos M; Foronjy R; Garcia-Arcos I PLoS One; 2020; 15(2):e0228279. PubMed ID: 32027677 [TBL] [Abstract][Full Text] [Related]
35. Bronchoalveolar lavage phospholipid abnormalities in HIV-infected patients. Escamilla R; Prevost MC; Cariven C; Hermant C; Krempf M; Chap H Eur Respir J; 1993 Oct; 6(9):1301-7. PubMed ID: 8287946 [TBL] [Abstract][Full Text] [Related]
36. [Effects of positive end expiratory pressure on pulmonary surfactant in patients undergoing one-lung ventilation]. Li HB; Zhang Y; Gao BB; Fu HQ; Deng JH Zhonghua Yi Xue Za Zhi; 2010 Jul; 90(25):1767-9. PubMed ID: 20979896 [TBL] [Abstract][Full Text] [Related]
37. Increased serum placental-like alkaline phosphatase activity in smokers originates from the lungs. Kallioniemi OP; Nieminen MM; Lehtinen J; Veneskoski T; Koivula T Eur J Respir Dis; 1987 Sep; 71(3):170-6. PubMed ID: 3678417 [TBL] [Abstract][Full Text] [Related]
38. Effects of ageing and smoking on SP-A and SP-D levels in bronchoalveolar lavage fluid. Betsuyaku T; Kuroki Y; Nagai K; Nasuhara Y; Nishimura M Eur Respir J; 2004 Dec; 24(6):964-70. PubMed ID: 15572540 [TBL] [Abstract][Full Text] [Related]
39. [Respiratory function and alveolar biological changes under the effect of CDP-choline in pulmonary interstitial pathology: pulmonary fibrosis and sarcoidosis]. Pacheco Y; Douss T; Pujol B; Revol A; Vergnon JM; Biot N; Brune J; Perrin-Fayolle M Rev Pneumol Clin; 1985; 41(2):91-100. PubMed ID: 3839593 [TBL] [Abstract][Full Text] [Related]
40. Elevated surfactant protein A in bronchoalveolar lavage fluids from sarcoidosis and hypersensitivity pneumonitis patients. Hamm H; Lührs J; Guzman y Rotaeche J; Costabel U; Fabel H; Bartsch W Chest; 1994 Dec; 106(6):1766-70. PubMed ID: 7988197 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]